We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $5.47B
1-Year Est. Return 131.34%
This Fund
S&P 500
This Quarter Est. Return
+6.31%
1 Year Est. Return
+131.34%
3 Year Est. Return
+363.85%
5 Year Est. Return
+515.73%
10 Year Est. Return
+2,786.05%
AUM
$3.92B
AUM Growth
-$967M
Cap. Flow
-$222M
Cap. Flow %
-5.66%
Top 10 Hldgs %
42.44%
Holding
108
New
15
Increased
23
Reduced
16
Closed
19

Top Buys

Rank Stock Value
1
MANE
Veradermics Inc
MANE
+$210M
2
CAPR icon
Capricor Therapeutics
CAPR
+$54.2M
3
VMC icon
Vulcan Materials
VMC
+$53.4M
4
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$46.6M
5
PFGC icon
Performance Food Group
PFGC
+$35.4M

Top Sells

Rank Stock Value
1
ERAS icon
Erasca
ERAS
+$131M
2
KO icon
Coca-Cola
KO
+$96.7M
3
MSFT icon
Microsoft
MSFT
+$64.7M
4
NOW icon
ServiceNow
NOW
+$59.7M
5
CRM icon
Salesforce
CRM
+$53M

Sector Composition

Rank Sector Weight
1 Healthcare 65.36%
2 Technology 6.7%
3 Miscellaneous 6.63%
4 Consumer Discretionary 5.89%
5 Financials 4.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GWW icon
76
W.W. Grainger
GWW
$61.5B
$1.09M 0.03%
+1,000
New +$1.09M
FTH
77
Faeth Therapeutics
FTH
$874M
$1.09M 0.03%
+34,549
New +$690K
WAT icon
78
Waters Corp
WAT
$40.7B
$960K 0.02%
3,225
+75
+2% +$25.7K
VST icon
79
Vistra
VST
$46B
$902K 0.02%
+6,000
New +$971K
IONS icon
80
Ionis Pharmaceuticals
IONS
$10.1B
$811K 0.02%
10,800
– –
A icon
81
Agilent Technologies
A
$43.4B
$569K 0.01%
4,990
– –
RMD icon
82
ResMed
RMD
$34.7B
$537K 0.01%
2,390
– –
SPOT icon
83
Spotify
SPOT
$113B
$533K 0.01%
+1,100
New +$552K
VLTO icon
84
Veralto
VLTO
$24B
$484K 0.01%
5,475
– –
RBLX icon
85
Roblox
RBLX
$27.5B
$476K 0.01%
+8,420
New +$565K
SRPT icon
86
Sarepta Therapeutics
SRPT
$2.2B
$389K 0.01%
17,888
– –
STE icon
87
Steris
STE
$22.8B
$338K 0.01%
1,530
– –
VRDN icon
88
Viridian Therapeutics
VRDN
$2.61B
$327K 0.01%
16,700
– –
ZBH icon
89
Zimmer Biomet
ZBH
$19.2B
$295K 0.01%
3,260
– –
ARKG icon
90
PUT
ARK Genomic Revolution ETF
ARKG
$1.88B
– –
-8,342,300
Closed -$242M
BIIB icon
91
Biogen
BIIB
$32.3B
– –
-132,290
Closed -$23.3M
CMG icon
92
Chipotle Mexican Grill
CMG
$48.1B
– –
-686,300
Closed -$25.4M
CRL icon
93
Charles River Laboratories
CRL
$13.9B
– –
-1,010
Closed -$201K
CRM icon
94
Salesforce
CRM
$211B
– –
-199,900
Closed -$53M
DKS icon
95
Dick's Sporting Goods
DKS
$12.1B
– –
-114,300
Closed -$22.6M
EXAS
96
DELISTED
Exact Sciences
EXAS
– –
-94,100
Closed -$9.56M
GS icon
97
Goldman Sachs
GS
$301B
– –
-24,108
Closed -$21.2M
HIMS icon
98
PUT
Hims & Hers Health
HIMS
$6.73B
– –
-2,559,400
Closed -$83.1M
INSM icon
99
Insmed
INSM
$25.9B
– –
-109,313
Closed -$19M
KO icon
100
Coca-Cola
KO
$386B
– –
-1,382,750
Closed -$96.7M
1 2 3
4
5

Similar funds

NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
ENV
Exor N.V. Amsterdam, Netherlands $5.46B AUM 6.21% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return

Suvretta Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Suvretta Capital Management held 108 positions worth $3.92B, down 20% from $4.88B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Suvretta Capital Management withdrew a net $222M in Q1 2026, closing 19 positions and reducing 16 holdings. Its most notable exit was Coca-Cola, an estimated $96.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, up from 51% a quarter earlier, followed by Technology and Miscellaneous.

Against the trend, Suvretta Capital Management opened a new position in Veradermics Inc worth $263M.

  • Suvretta Capital Management's largest Q1 2026 buy was Veradermics Inc: 4,168,970 shares worth $263M.
  • Suvretta Capital Management added most to Capricor Therapeutics in Q1 2026, an estimated $54.2M increase.
  • Suvretta Capital Management's biggest Q1 2026 reduction was Erasca, cutting an estimated $131M.
  • Suvretta Capital Management fully exited Coca-Cola in Q1 2026, selling an estimated $96.7M.
  • Suvretta Capital Management's ten largest holdings make up 42% of its $3.92B portfolio in Q1 2026.
  • Suvretta Capital Management opened 15 new positions and closed 19 in Q1 2026.
  • Suvretta Capital Management's portfolio value fell 20% quarter-over-quarter to $3.92B.

Based on Suvretta Capital Management's 13F filing for Q1 2026, filed 15 May 2026.